Conference calls for improved preventive action and treatment for rabies

| June 17, 2024 | India, Medical, Public health, Vaccination | No Comments

The FNDR (Foundation for Neglected Disease Research, a not-for-profit organization biotech R & D organization, brought together domain experts to discuss developments. Dr Shridhar Narayanan, CEO FNDR, explained that they were trying to design a drug that is effective in patients even after the rabies virus enters the brain. Currently there are no approved small molecule drugs for rabies; the antibodies don’t cross into the brain due to their large size. Dr. Rudramurthy, senior scientist, virology FNDR, emphasized the organization’s work in bringing veterinarians, medical doctors, researchers and industry experts together to ‘bring the count of neglected viral diseases to zero’.

ACCRECENT will keep track of these new treatment opportunities-as they will be great CME topics as soon as they become available for clinical use.

Rabies & KFD Conference 2024 | Foundation For Neglected Disease Research

Add a comment

Your email address will not be published. Required fields are marked *


COOKIE INFORMATION : CMEPEDIA uses cookies to enhance the user experience, keep statistics and to enable the sharing of pages on social media. By using this site, you agree to our use of cookies.